[
  {
    "ts": null,
    "headline": "PTC Inc. (PTC) Up 0.1% Since Last Earnings Report: Can It Continue?",
    "summary": "PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=fd856265d3cb54dfe372680dbe8f5f47c13ed610f720308b63192f6773a92745",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756481416,
      "headline": "PTC Inc. (PTC) Up 0.1% Since Last Earnings Report: Can It Continue?",
      "id": 136573201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PTC",
      "source": "Yahoo",
      "summary": "PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=fd856265d3cb54dfe372680dbe8f5f47c13ed610f720308b63192f6773a92745"
    }
  },
  {
    "ts": null,
    "headline": "PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia",
    "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. PTC Therapeutics, Inc. is one of them. PTC Therapeutics, Inc. (NASDAQ:PTCT) is a biotechnology company focused on developing treatments for rare disorders, including Duchenne muscular dystrophy, AADC deficiency, and phenylketonuria (PKU), with an active pipeline in rare disease […]",
    "url": "https://finnhub.io/api/news?id=de4c1fb57252b432df6b9e7e76d2f527a3bb64f075b4aa0e7a1b7d64b81ffe0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756457559,
      "headline": "PTC Therapeutics, Inc. (PTCT) Faces FDA Setback on Vatiquinone for Friedreich’s Ataxia",
      "id": 136569753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PTC",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. PTC Therapeutics, Inc. is one of them. PTC Therapeutics, Inc. (NASDAQ:PTCT) is a biotechnology company focused on developing treatments for rare disorders, including Duchenne muscular dystrophy, AADC deficiency, and phenylketonuria (PKU), with an active pipeline in rare disease […]",
      "url": "https://finnhub.io/api/news?id=de4c1fb57252b432df6b9e7e76d2f527a3bb64f075b4aa0e7a1b7d64b81ffe0c"
    }
  }
]